Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (231-240 of 347) with videos related to

Pageof 35
Sort By:
The Journal of Clinical Investigation|January 7, 2015
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
Haematologica|January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogoninClaudia Dürr, Bola S Hanna, Angela Schulz, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Nestin expression identifies ependymoma patients with poor outcomeTill Milde, Thomas Hielscher, Hendrik Witt, et al.
Blood|March 21, 2009
Induction of angiogenesis by normal and malignant plasma cellsDirk Hose, Jérôme Moreaux, Tobias Meissner, et al.
International Journal of Cancer|January 25, 2022
A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trialChristian Arsov, Peter Albers, Kathleen Herkommer, et al.
The Journal of Clinical Investigation|March 3, 2015
Corrigendum. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratificationAndrey Korshunov, Marc Remke, Wiebke Werft, et al.
Epigenetics|April 2, 2019
Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancerSonja Neumeyer, Odilia Popanda, Dominic Edelmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Adult medulloblastoma comprises three major molecular variantsMarc Remke, Thomas Hielscher, Paul A Northcott, et al.
Hemasphere|April 27, 2023
Palbociclib in Acute Leukemias With <i>KMT2A</i>-rearrangement: Results of AMLSG 23-14 TrialVerena I Gaidzik, Peter Paschka, Richard F Schlenk, et al.
Pageof 35

Showing results (231-240 of 347) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Investigation|January 7, 2015
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
Haematologica|January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogoninClaudia Dürr, Bola S Hanna, Angela Schulz, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Nestin expression identifies ependymoma patients with poor outcomeTill Milde, Thomas Hielscher, Hendrik Witt, et al.
Blood|March 21, 2009
Induction of angiogenesis by normal and malignant plasma cellsDirk Hose, Jérôme Moreaux, Tobias Meissner, et al.
International Journal of Cancer|January 25, 2022
A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trialChristian Arsov, Peter Albers, Kathleen Herkommer, et al.
The Journal of Clinical Investigation|March 3, 2015
Corrigendum. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratificationAndrey Korshunov, Marc Remke, Wiebke Werft, et al.
Epigenetics|April 2, 2019
Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancerSonja Neumeyer, Odilia Popanda, Dominic Edelmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Adult medulloblastoma comprises three major molecular variantsMarc Remke, Thomas Hielscher, Paul A Northcott, et al.
Hemasphere|April 27, 2023
Palbociclib in Acute Leukemias With <i>KMT2A</i>-rearrangement: Results of AMLSG 23-14 TrialVerena I Gaidzik, Peter Paschka, Richard F Schlenk, et al.
Pageof 35